-+ 0.00%
-+ 0.00%
-+ 0.00%

NXERA PHARMA CO. - TARGETS REGULATORY APPROVAL FOR VAMOROLONE IN SOUTH KOREA IN Q3 2027

Reuters·11/06/2026 08:44:23

Please log in to view news